{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T21:15:30Z","timestamp":1788988530159,"version":"build-2803163510"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T00:00:00Z","timestamp":1692144000000},"content-version":"vor","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001316","name":"Abbott","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Incomplete left atrial appendage occlusion (LAAO) due to peri-device leak (PDL) is a limitation of the therapy. The Amulet IDE trial is the largest randomized head-to-head trial comparing the Amulet and Watchman 2.5 LAAO devices with fundamentally different designs. The predictors and mechanistic factors impacting differences in PDLs within the Amulet IDE trial are assessed in the current analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>An independent core lab analysed all images for the presence or absence of severe PDL (&amp;gt;5\u2005mm). The incidence, mechanistic factors, predictors using propensity score-matched controls, and evolution of severe PDLs through 18 months were assessed. Of the 1878 patients randomized in the trial, the Amulet occluder had significantly fewer severe PDLs than the Watchman device at 45 days (1.1 vs. 3.2%, P &amp;lt; 0.001) and 12 months (0.1 vs. 1.1%, P &amp;lt; 0.001). Off-axis deployment or missed lobes were leading mechanistic PDL factors in each device group. Larger left atrial appendage (LAA) dimensions including orifice diameter, landing zone diameter, and depth predicted severe PDL with the Watchman device, with no significant anatomical limitations noted with the Amulet occluder. Procedural and device implant predictors were found with the Amulet occluder attributed to the learning curve with the device. A majority of Watchman device severe PDLs did not resolve over time through 18 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The dual-occlusive Amplatzer Amulet LAA occluder provided improved LAA closure compared with the Watchman 2.5 device. Predictors and temporal observations of severe PDLs were identified in the Amulet IDE trial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial registration<\/jats:title>\n                    <jats:p>https:\/\/clinicaltrials.gov Unique identifier NCT02879448.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/europace\/euad237","type":"journal-article","created":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T00:45:19Z","timestamp":1692060319000},"source":"Crossref","is-referenced-by-count":33,"title":["Mechanisms, predictors, and evolution of severe peri-device leaks with two different left atrial appendage occluders"],"prefix":"10.1093","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1492-2693","authenticated-orcid":false,"given":"Dhanunjaya","family":"Lakkireddy","sequence":"first","affiliation":[{"name":"Kansas City Heart Rhythm Institute and Research Foundation , 5100 W 100th St, Suite-200, Overland Park, KS 66211 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6473-2900","authenticated-orcid":false,"given":"Jens Erik","family":"Nielsen-Kudsk","sequence":"additional","affiliation":[{"name":"Aarhus University Hospital , Aarhus N , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2653-6762","authenticated-orcid":false,"given":"Stephan","family":"Windecker","sequence":"additional","affiliation":[{"name":"Inselspital, Bern University Hospital, University of Bern , Bern , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Thaler","sequence":"additional","affiliation":[{"name":"Tufts Medical Center , Boston, MA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J","family":"Price","sequence":"additional","affiliation":[{"name":"Scripps Clinic , La Jolla, CA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4677-8734","authenticated-orcid":false,"given":"Alok","family":"Gambhir","sequence":"additional","affiliation":[{"name":"Northside Hospital Cardiovascular Institute , Atlanta, GA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Gupta","sequence":"additional","affiliation":[{"name":"Los Angeles Medical Center , Los Angeles, CA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5889-0865","authenticated-orcid":false,"given":"Konstantinos","family":"Koulogiannis","sequence":"additional","affiliation":[{"name":"Cardiovascular Core Lab at Morristown Medical Center , Morristown, NJ , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1463-885X","authenticated-orcid":false,"given":"Leo","family":"Marcoff","sequence":"additional","affiliation":[{"name":"Cardiovascular Core Lab at Morristown Medical Center , Morristown, NJ , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5336-9149","authenticated-orcid":false,"given":"Anuj","family":"Mediratta","sequence":"additional","affiliation":[{"name":"Cardiovascular Core Lab at Morristown Medical Center , Morristown, NJ , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6983-1019","authenticated-orcid":false,"given":"Jordan A","family":"Anderson","sequence":"additional","affiliation":[{"name":"Abbott Structural Heart , Plymouth, MN , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4247-2163","authenticated-orcid":false,"given":"Ryan","family":"Gage","sequence":"additional","affiliation":[{"name":"Abbott Structural Heart , Plymouth, MN , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7333-5720","authenticated-orcid":false,"given":"Christopher R","family":"Ellis","sequence":"additional","affiliation":[{"name":"Vanderbilt Heart Institute , Nashville, TN , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,8,16]]},"reference":[{"key":"2023081608374634900_euad237-B1","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1161\/CIRCULATIONAHA.121.057063","article-title":"Amplatzer Amulet left atrial appendage occluder versus Watchman device for stroke prophylaxis (Amulet IDE): a randomized, controlled trial","volume":"144","author":"Lakkireddy","year":"2021","journal-title":"Circulation"},{"key":"2023081608374634900_euad237-B2","first-page":"171","article-title":"Left atrial appendage closure: what the evidence does and does not reveal-a view from the outside","volume":"11","author":"Saraf","year":"2022","journal-title":"Interv Cardiol Clin"},{"key":"2023081608374634900_euad237-B3","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.jcin.2023.01.011","article-title":"SCAI\/HRS expert consensus statement on transcatheter left atrial appendage closure","volume":"16","author":"Saw","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"2023081608374634900_euad237-B4","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4244\/EIJ-D-17-00866","article-title":"Impact of left atrial appendage morphology on indication and procedural outcome after interventional occlusion: results from the prospective multicentre German LAARGE registry","volume":"14","author":"Fastner","year":"2018","journal-title":"EuroIntervention"},{"key":"2023081608374634900_euad237-B5","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.jacep.2018.09.007","article-title":"Incidence and clinical impact of device-related thrombus following percutaneous left atrial appendage occlusion: a meta-analysis","volume":"4","author":"Alkhouli","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"key":"2023081608374634900_euad237-B6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jacep.2021.06.018","article-title":"Temporal changes and clinical implications of delayed peridevice leak following left atrial appendage closure","volume":"8","author":"Afzal","year":"2022","journal-title":"JACC Clin Electrophysiol"},{"key":"2023081608374634900_euad237-B7","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jacep.2022.03.001","article-title":"Clinical impact of residual leaks following left atrial appendage occlusion: insights from the NCDR LAAO registry","volume":"8","author":"Alkhouli","year":"2022","journal-title":"JACC Clin Electrophysiol"},{"key":"2023081608374634900_euad237-B8","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/j.jcin.2022.09.001","article-title":"Peridevice leak after transcatheter left atrial appendage occlusion: an analysis of the Amulet IDE trial","volume":"15","author":"Price","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"2023081608374634900_euad237-B9","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jacc.2022.04.062","article-title":"Impact of peridevice leak on 5-year outcomes after left atrial appendage closure","volume":"80","author":"Dukkipati","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2023081608374634900_euad237-B10","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jacc.2011.11.028","article-title":"The clinical impact of incomplete left atrial appendage closure with the Watchman device in patients with atrial fibrillation: a PROTECT AF (percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation) substudy","volume":"59","author":"Viles-Gonzalez","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2023081608374634900_euad237-B11","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1093\/eurheartj\/ehaa169","article-title":"Left atrial appendage occlusion with the Amplatzer Amulet device: full results of the prospective global observational study","volume":"41","author":"Hildick-Smith","year":"2020","journal-title":"Eur Heart J"},{"key":"2023081608374634900_euad237-B12","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jcin.2016.11.029","article-title":"Incidence and clinical impact of device-associated thrombus and peri-device leak following left atrial appendage closure with the Amplatzer cardiac plug","volume":"10","author":"Saw","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"2023081608374634900_euad237-B13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ahj.2018.12.010","article-title":"Rationale and design for AMPLATZER Amulet left atrial appendage occluder IDE randomized controlled trial (Amulet IDE trial)","volume":"211","author":"Lakkireddy","year":"2019","journal-title":"Am Heart J"},{"key":"2023081608374634900_euad237-B14","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/j.1540-8167.2010.01814.x","article-title":"Left atrial appendage studied by computed tomography to help planning for appendage closure device placement","volume":"21","author":"Wang","year":"2010","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2023081608374634900_euad237-B15","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/24748706.2019.1663381","article-title":"Characteristics and management of persistent peri-device flow after percutaneous left atrial appendage occlusion","volume":"3","author":"Alkhouli","year":"2019","journal-title":"Struct Heart"},{"key":"2023081608374634900_euad237-B16","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.jcin.2019.02.003","article-title":"Incidence, characterization, and clinical impact of device-related thrombus following left atrial appendage occlusion in the prospective global AMPLATZER Amulet observational study","volume":"12","author":"Aminian","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"2023081608374634900_euad237-B17","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"2023081608374634900_euad237-B18","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/europace\/euaa262","article-title":"Comparative data on left atrial appendage occlusion efficacy and clinical outcomes by age group in the Amplatzer Amulet Occluder Observational Study","volume":"23","author":"Freixa","year":"2021","journal-title":"Europace"},{"key":"2023081608374634900_euad237-B19","first-page":"39","article-title":"Systematic review and meta-analysis of all the currently available left atrial appendage closure device\u2019s peri device leak rate at 45-day follow up","volume":"15","author":"Salagundla","year":"2022","journal-title":"J Atr Fibrillation Electrophysiol"},{"key":"2023081608374634900_euad237-B20","doi-asserted-by":"crossref","first-page":"e944","DOI":"10.4244\/EIJ-D-21-00320","article-title":"Prevalence, mechanisms and impact of residual patency and device-related thrombosis following left atrial appendage occlusion: a computed tomography analysis","volume":"17","author":"Agudelo","year":"2021","journal-title":"EuroIntervention"},{"key":"2023081608374634900_euad237-B21","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/ccd.30406","article-title":"Usefulness of a novel sizing chart for left atrial appendage occlusion with the Amplatzer Amulet","volume":"100","author":"Freixa","year":"2022","journal-title":"Catheter Cardiovasc Interv"},{"key":"2023081608374634900_euad237-B22","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jcin.2023.01.008","article-title":"Impact of computational modeling on transcatheter left atrial appendage closure efficiency and outcomes","volume":"16","author":"Backer","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"2023081608374634900_euad237-B23","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1093\/europace\/euad049","article-title":"Outcomes of percutaneous left atrial appendage occlusion device implantation in atrial fibrillation patients based on underlying stroke risk","volume":"25","author":"Messele","year":"2023","journal-title":"Europace"},{"key":"2023081608374634900_euad237-B24","doi-asserted-by":"crossref","first-page":"e026295","DOI":"10.1161\/JAHA.122.026295","article-title":"Two-year outcomes with a next-generation left atrial appendage device: final results of the PINNACLE FLX trial","volume":"12","author":"Doshi","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"2023081608374634900_euad237-B25","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jcin.2020.10.034","article-title":"Peridevice leak following Amplatzer left atrial appendage occlusion: cardiac computed tomography classification and clinical outcomes","volume":"14","author":"Korsholm","year":"2021","journal-title":"JACC Cardiovasc Interv"}],"container-title":["Europace"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/25\/9\/euad237\/51114353\/euad237.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/25\/9\/euad237\/51114353\/euad237.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T04:38:07Z","timestamp":1692160687000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/doi\/10.1093\/europace\/euad237\/7242896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,2]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,8,2]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euad237","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,9]]},"published":{"date-parts":[[2023,8,2]]},"article-number":"euad237"}}